APA

Preda C. M., Popescu C. P., Baicus C., Constantinescu I., Oproiu A., Voiosu T., Diculescu M., Negreanu L., Gheorghe L., Sporea I., Trifan A., Ceausu E., Proca D. & Manuc M. (20181015). Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin. : Journal of viral hepatitis.

Chicago

Preda C M, Popescu C P, Baicus C, Constantinescu I, Oproiu A, Voiosu T, Diculescu M, Negreanu L, Gheorghe L, Sporea I, Trifan A, Ceausu E, Proca D and Manuc M. 20181015. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin. : Journal of viral hepatitis.

Harvard

Preda C. M., Popescu C. P., Baicus C., Constantinescu I., Oproiu A., Voiosu T., Diculescu M., Negreanu L., Gheorghe L., Sporea I., Trifan A., Ceausu E., Proca D. and Manuc M. (20181015). Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin. : Journal of viral hepatitis.

MLA

Preda C M, Popescu C P, Baicus C, Constantinescu I, Oproiu A, Voiosu T, Diculescu M, Negreanu L, Gheorghe L, Sporea I, Trifan A, Ceausu E, Proca D and Manuc M. Risk of hepatitis B virus reactivation in hepatitis B virus + hepatitis C virus-co-infected patients with compensated liver cirrhosis treated with ombitasvir, paritaprevir/r + dasabuvir + ribavirin. : Journal of viral hepatitis. 20181015.